Neurološke manifestacije celijakije u odraslih: prikaz slučaja by Jagoda Stipić et al.
Acta clin Croat 2002; 41:41-44 Case Report
41
NEUROLOGIC MANIFESTATIONS IN ADULT CELIAC
DISEASE: CASE REPORT
Jagoda StipiÊ1, Zdravko PerkoviÊ2, Vesna Crnek-Kunstelj3, Maja Relja1, Asija StipiÊ-MarkoviÊ4 and
Franjo ©kreb5
1Department of Neurology, 2Department of Endocrinology, Zagreb University Hospital Center; 3Department of Biology,
Zagreb University School of Medicine; 4Department of Immunology and Pulmonology, Sveti Duh General Hospital;
5Department of Nuclear Medicine, Dubrava University Hospital, Zagreb, Croatia
SUMMARY · Celiac disease is more common than previously thought, and a high index of suspi-
cion is important in its diagnosis. Typically, cases of celiac disease present at the age of 5-24 months
with the symptoms of intestinal malabsorption, growth retardation, abnormal stools, abdominal dis-
tension, muscle wasting, hypotonia, poor appetite and low spirit. In adults, the symptoms of celiac
disease may be highly varied. The incidence of malignancies is also increased. Most of these are small
bowel lymphomas and carcinomas of the esophagus and colon. In some patients, the disease is asso-
ciated with clinical dysfunction of the nervous system, manifesting variably as encephalopathy, cer-
ebellar abnormalities, seizures, cerebral atrophy and dementia, brain stem encephalitis, cerebral vas-
culitis, myopathy, quadriparesis (metabolic), myelopathy, peripheral neuropathy, multifocal leukoen-
cephalopathy, and psychiatric disorders. Presentation is made of a 47-year-old woman with misdiag-
nosed celiac disease, who first developed pain in the back which was treated with spinal support. She
also complained of very severe bone pains. Finally, she was admitted to the hospital with a history of
increasing difficulty on walking, weakness in her legs, urine incontinence, and 5-kg weight loss in
four months. Celiac disease should therefore be considered on differential diagnosis in patients pre-
senting with unexplained neurologic symptoms.
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abdominal pain and bloating, flatulence, and even consti-
pation. The disorder manifested with neurologic symptoms,
severe pain in the back and bones, paraparesis, urine incon-
tinence, fatigue, headache, and depression. At first we
thought the symptoms to be caused by a malignant disease.
Case Report
A 47-year-old woman, completely healthy until two
years before, had since been experiencing severe pain in the
back, then in both legs. Physical therapy had resulted in
only transient improvement. Radiographic vertebral scan
and EMNG revealed no pathologic alterations. For about
one year, the pain increased in frequency and severity, ra-
diating to both legs, the patient walked with difficulty, es-
Introduction
Celiac disease (CD) is more prevalent than previously
believed and is frequently underdiagnosed, particularly in
adults who may present with subtle symptoms. The vari-
able clinical presentation in CD reflects the diverse patho-
logic expression of this multisystem disorder. Neurologic
complications occur in about 10% of CD patients1.
We describe a female patient without any specific symp-
toms of CD such as diarrhea with bulky, offensive stools,
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pecially upstairs. Additional physical therapy failed to pro-
duce any improvement. One month before hospitalization,
the patient could not walk without help and suffered urine
incontinence. Over the preceding four months, she unin-
tentionally lost approximately 5 kg in weight. For all these
symptoms, she was admitted to the Department of Neu-
rology, Zagreb University Hospital Center.
The patient was 162 cm tall, her body weight was 48
kg and body mass index (BMI) 18 kg/m2, which is below
the normal values. Her skin and mucosa were normal, she
was well hydrated, with no signs of bleeding. Arterial pres-
sure was 120/70 mm Hg and pulse 80/min. She had pedal
edema with normal peripheral arterial pulsations. Neuro-
logic examination revealed flaccid paraparesis with weaker
tendon reflexes, flexor plantar responses, and urine incon-
tinence. There was no loss of pain, touch or thermal sen-
sation.
Laboratory tests showed mild normocytic anemia (E
3.89, Hb 118, He 0.35, MCV 91), low total serum pro-
tein (48 g/L), albumin (26.4 g/L) and gamma-globulin
(7.9 g/L). The level of calcium was 2.11 mmol/L, calcium
in 24-hour urine 1.62 mmol/L, and phosphorus 0.67
mmol/L; serum prothrombin activity, magnesium, ionic
calcium and APTV were normal; alkaline phosphatase
was 355 U/L. Dynamic changes of total alkaline phos-
phatase in peripheral blood during hospital treatment are
shown in Fig. 1.
The patient had positive serum HLA-B8 and HLA-
DR3 histocompatibility antigens. EMNG showed a minor
L5 radix lesion bilaterally. Computed tomography (CT)
showed lesions in the brain white matter. Radiologic stud-
ies of the vertebral spine, pelvis and both femurs revealed
signs of osteomalacia. Also, the patient had an abnormally
low BMD. Hypoproteinemia, elevated values of alkaline
phosphatase, radiographic scans, and low BMD indicated
osteomalacia, which in turn strongly pointed to the diag-
nosis of protein and vitamin D malabsorption.
Later, laboratory findings showed low folic acid of 4
(normal 7-28) nmol/L, 25-hydroxyvitamin D of 1.5 (nor-
mal 22-190) nmol/L, normal B12 value, and increased
PTH of 16.8 (normal 1-6) pmol/L.
Positive antiendomysium IgA antibodies were re-
corded, and small intestine biopsy was indicated, which
revealed villous atrophy. Characteristic changes included
flattening or loss of villi, hyperplasia of mucosal crypts,
and increased intraepithelial lymphocyte count. Small
intestinal mucosa showed total atrophy of intestinal epi-
thelium with moderate to abundant lymphocytic infil-
trates in lamina propria (Fig. 2).
Based on these findings, gluten enteropathy with mal-
absorption of protein, vitamins D and K, and folic acid,
with consequential hyperparathyroidism and osteomala-
cia were diagnosed. Therapy with a non-gluten diet and
oral substitution of folic acid, active vitamin D (0.75 mg/
day), vitamin K by infusion, calcium and phosphates in
dairy products and tablets was initiated. With this therapy,
leg edema disappeared. Serum calcium, phosphorus and
prothrombin complex normalized, and body weight in-
creased by 3 kg. Bone pain diminished and muscle
strength increased. After 3 months of gluten-free diet,
weight gain of 12 kg was recorded, along with normaliza-
tion of all hematology and clinical chemistry findings, and
24-urine calcium decrease (1.6 mmol/d/U). The patient
was now able to walk independently, and felt some pain
Fig. 1. Changes in peripheral blood alkaline phosphatase.
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Fig. 2. In our patient, small intestinal mucosa showed total atrophy
of intestinal epithelium, with moderate to abundant lymphocytic
infiltrations in lamina propria.
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in her bones and back only on climbing upstairs. Now she
had urination control again, and generally felt much bet-
ter, free from episodes of depression.
Discussion
Celiac disease results from an abnormal immune re-
sponse to gliadin, a component of dietary gluten, found in
wheat, barley, rye and possibly oats. This response causes
villous atrophy of small intestinal mucosa, which in turn
leads to malabsorption and predisposes to gastrointestinal
malignancy, especially carcinoma of the oropharynx and
esophagus, and small bowel lymphoma2. Gluten sensitive
enteropathy straddles the realms of food hypersensitivity
and autoimmunity, and the way in which these two pro-
cesses are able to combine to produce small intestine mu-
cosal damage has been an area of much controversy. How-
ever, with recent advances in the study of CD, especially
identification of the antigenic target transglutaminase, a
model of celiac pathogenesis has become possible to design.
An initial mucosal damage, possibly due to intestinal
infection or even toxic effect of gliadin, upregulates tis-
sue transglutaminase (tTG). This enzyme causes cross-
linking of various proteins, including gliadin. This tTG
gliadin complex represents a ‘new antigen’ (neoantigen),
which could then trigger the production of anti-tTG an-
tibodies. Gliadin specific CD4+ T-helper cells (which
exist in small bowel mucosa of CD patients) provide help
for the production of anti-tTG antibodies by tTG spe-
cific B cells. Transglutaminase plays a role in maintain-
ing the integrity of both intestinal crypt microarchitecture
and dermoepidermal junction, so the development of vil-
lous atrophy and dermatitis herpetiformis lesions could be
explained by this final common pathway3,4.
An immunologic mechanism involving both small
bowel and brain tissue has been suggested as a possible
cause5. It has also been postulated that adults with CD
may be at a risk of superimposed neurologic disease of the
central nervous system due to the permenant or intermit-
tent state of immunodeficiency6.
There may be a genetic role as there is an increased
incidence of HLA-B8 and HLA-DR3 in CD patients7.
Also, there is the possibility of a viral role based on the
homology of 12-amino acid sequence, human type 12 ad-
enovirus E1b protein in alpha-gliadin fraction. Although
the mechanism is not known, a damage is known to occur.
IgA antibodies to gliadin, endomysium and/or tTG
are detectable in most untreated patients. Antibody test-
ing should not be used to make the diagnosis because of
the possibility of false positive results. A definite diag-
nosis in both adults and children is based on the find-
ing of villous atrophy in the small intestinal mucosa bi-
opsy specimen. Serologic testing can help in the diag-
nosis of CD. Two tests are most commonly used:
antigliadin antibody (AGA) test and endomysial anti-
body (EMA) test. These are IgA antibodies. Testing for
IgG antibodies is of little diagnostic value, since the sen-
sitivity and specificity are only about 50%. More specific
tests for tTG antibodies have also been developed and
are likely to replace other tests when they become more
widely available8.
CD may occur at any age, even after the age of 70,
although in adults it usually occurs between the age of 20
and 60. In adults and adolescents, presentation with clas-
sical symptoms of diarrhea, weight loss and malnutrition,
or bone pain has become much less common. Mild and
subclinical forms are frequent, occurring in more than 50%
of patients. Atypical presentation may involve an other-
wise unexplained hematologic abnormality (iron defi-
ciency with or without anemia, folate deficiency, macro-
cytosis), constitutional symptoms, or fatigue with mini-
mal weight loss and no intestinal symptoms, or mild ab-
dominal or digestive complaints9.
Pedal edema and bruising can occur as a result of pro-
tein and vitamin K malabsorption. The metabolic role of
vitamin K is to facilitate carboxylation of glutamyl to γ-
carboxyglutamyl residues. Besides hepatic tissue, in
which the clotting factors are produced, γ-carboxyglu-
tamyl-containing proteins are also abundantly available
in bone tissue. Osteocalcin accounts for up to 80% of
total γ-carboxyglutamyl content of a mature bone. Hu-
man carboxylated osteocalcin contains three γ-carboxy-
glutamyl residues, which confer a highly specific affin-
ity to the calcium ion of the hydroxyapatite molecule.
Besides the γ-carboxylation of osteocalcin, vitamin K
may also affect either the parameters of bone metabo-
lism such as calcium hemostasis, or prostaglandin E2 and
interleukin-6 production. Evidence from observational
studies and first intervention trials indicate that the vi-
tamin K intake is much higher than the current recom-
mendations for improved biochemical markers of bone
formation and bone density10.
The most common cause of severe bone pain in un-
treated CD is osteomalacia, i.e. malformation of the bone
due to the lack of vitamin D and calcium. It affects mostly
the hips, and sometimes shoulders and back. It usually
improves with specific treatment, which includes gas-
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trointestinal diet for CD patients, vitamin D supplemen-
tation and other interventions.
Another cause of bone pain is osteoporosis. It can of-
ten cause pain in the back, due to vertebral shortening,
thus squeezing the nerves. It is a very painful condition
without any possibility to improve; once the vertebrae
have shortened, they cannot be stretched again to their
original size. Muscle pain can also occur because of vita-
min D deficiency.
CD may be associated with various neurologic mani-
festations. The most common conditions are polyneur-
opathy and spinocerebellar ataxia. Other conditions in-
clude motor neuron disease, myelopathy, epilepsy and en-
cephalopathy. Neurologic manifestations may precede
gastrointestinal symptoms11.This disorder affects pre-
dominantly the cerebellum, deep gray masses, brain-stem
nuclei, and spinal cord. Its cause and pathogenesis are un-
known7. Peripheral neuropathies of axonal and demyeli-
nating types have also been reported and may respond to
the elimination of gluten from the diet. Cases of myoclo-
nus, internuclear ophthalmoplegia, multifocal leukoen-
cephalopathy, and dementia have been described. The
mechanism underlying these processes remains obscure
but may be immunologic or related to trace vitamin defi-
ciencies. It has also been claimed that occult CD accounts
for a substantial proportion of patients with neurologic
dysfunction of unknown cause. Some authorities recom-
mend that cryptogenic ataxia and neuropathies be rou-
tinely screened for the presence of gluten sensitivity,
whereas other suggest that children with white matter
lesions should be tested for CD, even if free from intesti-
nal symptoms12.
Saæetak
NEUROLO©KE MANIFESTACIJE CELIJAKIJE U ODRASLIH: PRIKAZ SLU»AJA
J. StipiÊ, Z. PerkoviÊ, V. Crnek-Kunstelj, M. Relja, A. StipiÊ-MarkoviÊ i F. ©kreb
Celijakija je uËestalija nego ¹to se misli i to treba uzeti u obzir pri diferencijalnoj dijagnostici nejasnih neurolo¹kih sindroma.
ObiËno se javlja u dobi od 5-24 mjeseca sa znacima crijevne malapsorpcije, zaostajanjem u rastu, naduto¹Êu uz uËestale stolice,
slabost mi¹iÊa, hipotoniju, slab apetit i neraspoloæenje. U odraslih znaci celijakije mogu biti razliËiti. UËestalost malignoma takoðer
je poveÊana. U nekih je bolesnika celijakija povezana sa znacima o¹teÊenja æivËanoga sustava poput encefalopatije, cerebelarne
simptomatologije, cerebralne atrofije, demencije, cerebralnog vaskulitisa, miopatije, oduzetosti ekstremiteta, periferne neuropatije,
vi¹eæari¹ne encefalopatije i psihijatrijskih poremeÊaja. Opisana je 47-godi¹nja bolesnica s nedijagnosticiranom celijakijom, u koje
je prvi simptom bila intenzivna bol u leðima, zbog koje je provodila fizikalnu rehabilitaciju. Nakon toga javili su se difuzni bolovi
u kostima uz te¹koÊe pri hodu, a potom napredujuÊa slabost donjih ekstremiteta. Zbog flacidne parapareze, smetnji mokrenja i
gubitka tjelesne teæine bolesnica je primljena na bolniËko lijeËenje. Dakle, u bolesnika s nejasnom neurolo¹kom simptomatologijom
treba u obzir uzeti i moguÊnost da se primarno radi o celijakiji.
KljuËne rijeËi: Celijakija, komplikacije; Bolesti æivËanoga sustava, komplikacije; Celijakija, dijagnostika; Prikaz sluËaja; Odrasla osoba
In conclusion, CD should be considered on the dif-
ferential diagnosis in patients presenting with unexplained
neurologic symptoms.
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